{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:40:36Z","timestamp":1761716436833},"reference-count":38,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2000,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Foscarnet (trisodium phosphonoformate hexahydrate) is an antiviral agent used to treat cytomegalovirus disease in immunocompromised patients. One common side effect is acute ionized hypocalcemia and hypomagnesemia following intravenous administration. Foscarnet-induced ionized hypomagnesemia might contribute to ionized hypocalcemia by impairing excretion of preformed parathyroid hormone (PTH) or by producing target organ resistance. Prevention of ionized hypomagnesemia following foscarnet administration could blunt the development of ionized hypocalcemia. To determine whether intravenous magnesium ameliorates the decline in ionized calcium and\/or magnesium following foscarnet infusions, MgSO\n            <jats:sub>4<\/jats:sub>\n            at doses of 1, 2, and 3 g was administered in a double-blind, placebo-controlled, randomized, crossover trial to 12 patients with AIDS and cytomegalovirus disease. Overall, increasing doses of MgSO\n            <jats:sub>4<\/jats:sub>\n            reduced or eliminated foscarnet-induced acute ionized hypomagnesemia. Supplementation, however, had no discernible effect on foscarnet-induced ionized hypocalcemia despite significant increases in serum PTH levels. No dose-related, clinically significant adverse events were found, suggesting that intravenous supplementation with up to 3 g of MgSO\n            <jats:sub>4<\/jats:sub>\n            was safe in this chronically ill population. Since parenteral MgSO\n            <jats:sub>4<\/jats:sub>\n            did not alter foscarnet-induced ionized hypocalcemia or symptoms associated with foscarnet, routine intravenous supplementation for patients with normal serum magnesium levels is not recommended during treatment with foscarnet.\n          <\/jats:p>","DOI":"10.1128\/aac.44.8.2143-2148.2000","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:06:42Z","timestamp":1027764402000},"page":"2143-2148","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":31,"title":["A Double-Blind Placebo-Controlled Crossover Trial of Intravenous Magnesium Sulfate for Foscarnet-Induced Ionized Hypocalcemia and Hypomagnesemia in Patients with AIDS and Cytomegalovirus Infection"],"prefix":"10.1128","volume":"44","author":[{"given":"Mark M.","family":"Huycke","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Departments of Medicine1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Tarek","family":"Naguib","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Medicine1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias M.","family":"Stroemmel","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Medicine1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Blick","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Pathology,2 University of Oklahoma Health Sciences Center and Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma 73190, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Monti","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Astra USA, Inc., Westborough, Massachusetts 01581-45003"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Martin-Munley","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Astra USA, Inc., Westborough, Massachusetts 01581-45003"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Kaufman","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Medicine1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"297","article-title":"A new method for the rapid determination of ionized Mg2+ in whole blood, serum and plasma.","volume":"14","author":"Altura B. T.","year":"1992","unstructured":"Altura B. T. Shirey T. L. Young C. C. Hiti J. Dell'Orfano K. Handwerker S. M. Altura B. M. A new method for the rapid determination of ionized Mg2+ in whole blood, serum and plasma. Methods Find. Exp. Clin. Pharmacol. 14 1992 297 304","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1210\/jcem-42-4-707","article-title":"Impaired release of parathyroid hormone in magnesium deficiency.","volume":"42","author":"Anast C. S.","year":"1976","unstructured":"Anast C. S. Winnacker J. L. Forte L. R. Burns T. W. Impaired release of parathyroid hormone in magnesium deficiency. J. Clin. Endocrinol. Metab. 42 1976 707 717","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.5.742"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0146-0005(99)80061-5","article-title":"Prevention of eclampsia.","volume":"23","author":"Belfort M. A.","year":"1999","unstructured":"Belfort M. A. Anthony J. Saade G. R. Prevention of eclampsia. Semin. Perinatol. 23 1999 65 78","journal-title":"Semin. Perinatol."},{"key":"e_1_3_2_6_2","first-page":"210S","article-title":"Functional hypoparathyroidism induced by foscarnet in AIDS patients treated for CMV related disease is connected with low ionized magnesium: a breakthrough of its electrometric determination.","volume":"16","author":"Bourdeau A.","year":"1995","unstructured":"Bourdeau A. Dohin E. Kindermans C. Souberbielle J. C. Katlama C. Sachs C. Functional hypoparathyroidism induced by foscarnet in AIDS patients treated for CMV related disease is connected with low ionized magnesium: a breakthrough of its electrometric determination. Bone 16 1995 210S","journal-title":"Bone"},{"key":"e_1_3_2_7_2","first-page":"315","article-title":"Acute renal failure induced by foscarnet: 4 cases.","volume":"29","author":"Cacoub P.","year":"1988","unstructured":"Cacoub P. Deray G. Baumelou A. Le Hoang P. Rozenbaum W. Gentilini M. Soubrie C. Rousselie F. Jacobs C. Acute renal failure induced by foscarnet: 4 cases. Clin. Nephrol. 29 1988 315 318","journal-title":"Clin. Nephrol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJM198405103101904","article-title":"The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects.","volume":"310","author":"Cholst I. N.","year":"1984","unstructured":"Cholst I. N. Steinberg S. F. Tropper P. J. Fox H. E. Segre G. V. Bilezikian J. P. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N. Engl. J. Med. 310 1984 1221 1225","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/0002-9343(92)90329-A","article-title":"Mechanism of action of foscarnet against viral polymerases.","volume":"92","author":"Crumpacker C. S.","year":"1992","unstructured":"Crumpacker C. S. Mechanism of action of foscarnet against viral polymerases. Am. J. Med. 92 (Suppl. 2A) 1992 3S 7S","journal-title":"Am. J. Med."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000167987","article-title":"Foscarnet nephrotoxicity: mechanism, incidence and prevention.","volume":"9","author":"Deray G.","year":"1989","unstructured":"Deray G. Martinez F. Katlama C. Levaltier B. Beaufils H. Danis M. Rozenheim M. Baumelou A. Dohin E. Gentilini M. Jacobs C. Foscarnet nephrotoxicity: mechanism, incidence and prevention. Am. J. Nephrol. 9 1989 316 321","journal-title":"Am. J. Nephrol."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-110-9-710","article-title":"Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS): an uncontrolled trial.","volume":"110","author":"Erlich K. S.","year":"1989","unstructured":"Erlich K. S. Jacobson M. A. Koehler J. E. Follansbee S. E. Drennan D. P. Gooze L. Safrin S. Mills J. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS): an uncontrolled trial. Ann. Intern. Med. 110 1989 710 713","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1210\/jcem-29-6-842","article-title":"Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness.","volume":"29","author":"Estep H.","year":"1969","unstructured":"Estep H. Shaw W. A. Watlington C. Hobe R. Holland W. Tucker S. G. Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness. J. Clin. Endocrinol. Metab. 29 1969 842 848","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1365-2265.1985.tb00171.x","article-title":"Magnesium administration reverses the hypocalcaemia secondary to hypomagnesaemia despite low circulating levels of 25-hydroxy vitamin D and 1,25-dihydroxy vitamin D.","volume":"22","author":"Fuss M.","year":"1985","unstructured":"Fuss M. Cogan E. Gillet C. Karmali R. Geurts J. Bergans A. Brauman H. Bouillon R. Corvilain J. Magnesium administration reverses the hypocalcaemia secondary to hypomagnesaemia despite low circulating levels of 25-hydroxy vitamin D and 1,25-dihydroxy vitamin D. Clin. Endocrinol. 22 1985 807 815","journal-title":"Clin. Endocrinol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/106002809302700304","article-title":"Foscarnet-induced severe hypomagnesemia and other electrolyte disorders.","volume":"27","author":"Gearhart M. O.","year":"1993","unstructured":"Gearhart M. O. Sorg T. B. Foscarnet-induced severe hypomagnesemia and other electrolyte disorders. Ann. Pharmacother. 27 1993 285 289","journal-title":"Ann. Pharmacother."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00000542-199807000-00029","article-title":"Magnesium and cardiovascular disease.","volume":"89","author":"Gomez M. N.","year":"1998","unstructured":"Gomez M. N. Magnesium and cardiovascular disease. Anesthesiology 89 1998 222 240","journal-title":"Anesthesiology"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1086\/597645","article-title":"Unusual prolonged hypocalcemia due to foscarnet in a patient with AIDS.","volume":"25","author":"Guillaume M. P.","year":"1997","unstructured":"Guillaume M. P. Karmali R. Bergmann P. Cogan E. Unusual prolonged hypocalcemia due to foscarnet in a patient with AIDS. Clin. Infect. Dis. 25 1997 932 933","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1471-0528.1998.tb10084.x","article-title":"Magnesium sulphate: a review of clinical pharmacology applied to obstetrics.","volume":"105","author":"Idama T. O.","year":"1998","unstructured":"Idama T. O. Lindow S. W. Magnesium sulphate: a review of clinical pharmacology applied to obstetrics. Br. J. Obstet. Gynaecol. 105 1998 260 268","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"e_1_3_2_18_2","first-page":"S11","article-title":"Review of the toxicities of foscarnet.","volume":"5","author":"Jacobson M.","year":"1992","unstructured":"Jacobson M. Review of the toxicities of foscarnet. J. Acquir. Immune Defic. Syndr. 5 1992 S11 S17","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1210\/jcem-72-5-1130","article-title":"Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism.","volume":"72","author":"Jacobson M. A.","year":"1991","unstructured":"Jacobson M. A. Gambertoglio J. G. Aweeka F. T. Causey D. M. Portale A. A. Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. J. Clin. Endocrinol. Metab. 72 1991 1130 1135","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.5.736"},{"key":"e_1_3_2_21_2","first-page":"139","article-title":"Effects of infusions of magnesium and of calcium in parathyroid insufficiency.","volume":"30","author":"Jones K. H.","year":"1966","unstructured":"Jones K. H. Fourman P. Effects of infusions of magnesium and of calcium in parathyroid insufficiency. Clin. Sci. 30 1966 139 146","journal-title":"Clin. Sci."},{"key":"e_1_3_2_22_2","first-page":"S18","article-title":"Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens.","volume":"5","author":"Katlama C.","year":"1992","unstructured":"Katlama C. Dohin E. Caumes E. Cochereau-Massin I. Brancon C. Robinet M. Rogeaux O. Dahan R. Gentilini M. Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens. J. Acquir. Immune Defic. Syndr. 5 (Suppl. 1) 1992 S18 S24","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0026-0495(74)90050-X","article-title":"Hypocalcemia in magnesium-depleted dogs: evidence for reduced responsiveness to parathyroid hormone and relative failure of parathyroid gland function.","volume":"23","author":"Levi J.","year":"1974","unstructured":"Levi J. Massry S. G. Coburn J. W. Llach F. Kleeman C. R. Hypocalcemia in magnesium-depleted dogs: evidence for reduced responsiveness to parathyroid hormone and relative failure of parathyroid gland function. Metabolism 23 1974 323 335","journal-title":"Metabolism"},{"key":"e_1_3_2_24_2","first-page":"F301","article-title":"Dual action of phosphonoformic acid on Na+-phosphate cotransport in opossum kidney cells.","volume":"263","author":"Loghman-Adham M.","year":"1992","unstructured":"Loghman-Adham M. Dousa T. P. Dual action of phosphonoformic acid on Na+-phosphate cotransport in opossum kidney cells. Am. J. Physiol. 263 1992 F301 F310","journal-title":"Am. J. Physiol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/106002809402800908","article-title":"Neurologic sequelae associated with foscarnet therapy.","volume":"28","author":"Lor E.","year":"1994","unstructured":"Lor E. Liu Y. Q. Neurologic sequelae associated with foscarnet therapy. Ann. Pharmacother. 28 1994 1035 1037","journal-title":"Ann. Pharmacother."},{"key":"e_1_3_2_26_2","unstructured":"Neter\n              J.\n              Wasserman\n              W.\n              Kutner\n              M. H.\n          Applied linear statistical models\n          1990\n          1083\n          1117\n          Irwin\n          Boston Mass"},{"key":"e_1_3_2_27_2","first-page":"172","article-title":"Plasma and renal effects of foscarnet in HIV seropositive patients.","volume":"1","author":"Noormohamed F. H.","year":"1996","unstructured":"Noormohamed F. H. Youle M. S. Tang B. Martin-Munley S. Gazzard B. G. Lant A. F. Higgs C. J. Piner C. Plasma and renal effects of foscarnet in HIV seropositive patients. Antivir. Ther. 1 1996 172 179","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-9-665"},{"key":"e_1_3_2_29_2","first-page":"S3","article-title":"Foscarnet and ganciclovir in the treatment of cytomegalovirus retinitis.","volume":"5","author":"Polis M. A.","year":"1992","unstructured":"Polis M. A. Foscarnet and ganciclovir in the treatment of cytomegalovirus retinitis. J. Acquir. Immune Defic. Syndr. 5 (Suppl. 1) 1992 S3 S10","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ki.1997.443","article-title":"Renal magnesium handling: new insights in understanding old problems.","volume":"52","author":"Quamme G. A.","year":"1997","unstructured":"Quamme G. A. Renal magnesium handling: new insights in understanding old problems. Kidney Int. 52 1997 1180 1195","journal-title":"Kidney Int."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archinte.1993.00410090072009","article-title":"Hypermagnesemic pseudocoma.","volume":"153","author":"Rizzo M. A.","year":"1993","unstructured":"Rizzo M. A. Fisher M. Lock J. P. Hypermagnesemic pseudocoma. Arch. Intern. Med. 153 1993 1130 1132","journal-title":"Arch. Intern. Med."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0272-0590(92)90204-U","article-title":"Hypocalcemia induced by foscarnet (foscavir) infusion in dogs.","volume":"18","author":"Ryrfeldt A.","year":"1992","unstructured":"Ryrfeldt A. Nordgren T. Lundstrom J. Hypocalcemia induced by foscarnet (foscavir) infusion in dogs. Fundam. Appl. Toxicol. 18 1992 126 130","journal-title":"Fundam. Appl. Toxicol."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108223250805"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00000542-194205000-00010","article-title":"The pharmacological actions of parenterally administered magnesium salts: a review.","volume":"3","author":"Smith P. K.","year":"1942","unstructured":"Smith P. K. Winkler A. W. Hopp H. E. The pharmacological actions of parenterally administered magnesium salts: a review. Anesthesiology 3 1942 323 330","journal-title":"Anesthesiology"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archinte.1995.00430010071010","article-title":"Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial.","volume":"155","author":"Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group","year":"1995","unstructured":"Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Arch. Intern. Med. 155 1995 65 74","journal-title":"Arch. Intern. Med."},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archopht.1996.01100130021004","article-title":"Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The cytomegalovirus retreatment trial.","volume":"114","author":"Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group","year":"1996","unstructured":"Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The cytomegalovirus retreatment trial. Arch. Ophthalmol. 114 1996 23 33","journal-title":"Arch. Ophthalmol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0162-0134(00)80197-X"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF01711089","article-title":"High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus.","volume":"19","author":"Sydow M.","year":"1993","unstructured":"Sydow M. Crozier T. A. Zielmann S. Radke J. Burchardi H. High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus. Intensive Care Med. 19 1993 467 471","journal-title":"Intensive Care Med."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(97)10535-9","article-title":"Magnesium and phosphorus.","volume":"352","author":"Weisinger J. R.","year":"1998","unstructured":"Weisinger J. R. Bellor\u0131\u0301n-Font E. Magnesium and phosphorus. Lancet 352 1998 391 396","journal-title":"Lancet"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.44.8.2143-2148.2000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.44.8.2143-2148.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:43:39Z","timestamp":1645461819000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.44.8.2143-2148.2000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["10.1128\/AAC.44.8.2143-2148.2000"],"URL":"https:\/\/doi.org\/10.1128\/aac.44.8.2143-2148.2000","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]},"assertion":[{"value":"2000-02-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-05-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}